Elicio Therapeutics, a privately-held, clinical-stage biotechnology company developing a pipeline of novel immunotherapies for the treatment of cancer and other diseases, has entered into a definitive merger agreement with Angion Biomedica Corp (NASDAQ: ANGN) under which Elicio will merge with a wholly-owned subsidiary of Angi
Microsoft Corporation (NASDAQ: MSFT) was hit with another setback Monday over its bid to acquire Activision Blizzard, Inc (NASDAQ: ATVI), this time from the European Commission, which has concerns surrounding the deal.<
National Instruments Corp’s (NASDAQ:NATI) board evaluates strategic options in consultation with its financial and legal advisors. The comprehensive review will…
New Leaf Ventures Inc. (OTCPK:NLVVF) (CSE:NLV) has completed the acquisition of High Profile Holdings Corp. by way of a statutory three-cornered amalgamation.